Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Double-blind, Placebo-Controlled Study of TAK-861 in Healthy Adults, Elderly, and Narcolepsy Type 1
jRCT2071210007Phase 1Completed
- Sponsor
- Takeda
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of oveporexton in narcolepsy type 1 (NT1) (8 arms), sponsored by Takeda. Started Apr 2021; status: completed.
02
Drugs
oveporexton
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on jRCT2071210007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210007.